共 148 条
[1]
Forrest J.D., Fordyce R.R., U.S. woman’s contraceptive attitudes and practice: how have they changed in the 1980’s?, Fam Plann Perspect, 20, pp. 112-8, (1988)
[2]
Vessey M., Lawless M., Yeates D., Efficacy of different contraceptive methods, Lancet, 1, pp. 841-2, (1982)
[3]
Meade T.W., Greenberg G., Thompson S.G., Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of 50- and 30- µg estrogen preparations, Br Med J, 280, pp. 1157-61, (1980)
[4]
Bottiger L.E., Boman G., Eklund G., Westerholm B., Oral contraceptives and thromboembolic disease: effects of lowering estrogen content, Lancet, 1, pp. 1097-101, (1980)
[5]
Porter J.B., Jick H., Walker A.M., Mortality among oral contraceptive users, Obstet Gynecol, 70, pp. 29-32, (1987)
[6]
Meade T.W., Oral contraceptives, clotting factors and thrombosis, Am J Obstet Gynecol, 142, pp. 758-61, (1982)
[7]
Zafrani E.S., Pinaudeau Y., Dhumeaux D., Drug-induced vascular lesions of the liver, Arch Intern Med, 143, pp. 495-502, (1983)
[8]
Oral contraception and increased risk of cerebral ischemia or thrombosis, N Engl J Med, 288, pp. 871-8, (1973)
[9]
Connell E.B., Oral contraceptives. The current risk-benefit ratio, J Reprod Med, 29, pp. 513-23, (1984)
[10]
Wynn V., Godsland I., Effects of oral contraceptives on carbohydrate metabolism, J Reprod Med, 31, pp. 898-905, (1986)